CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 149,883	$ 126,450
Restricted cash	7,475	12,413
Patient accounts receivable	356,909	313,373
Prepaid expenses	15,510	14,639
Other current assets	26,125	30,060
Total current assets	555,902	496,935
Property and equipment, net of accumulated depreciation of $98,850 and $92,422	44,654	41,845
Operating lease right of use assets	84,692	88,939
Goodwill	1,244,679	1,244,679
Intangible assets, net of accumulated amortization of $16,259 and $14,008	100,832	102,675
Other assets	86,609	85,097
Total assets	2,117,368	2,060,170
Current liabilities:
Accounts payable	26,626	28,237
Payroll and employee benefits	136,118	136,835
Accrued expenses	147,038	140,049
Termination fee paid by UnitedHealth Group	106,000	106,000
Current portion of long-term obligations	37,747	36,314
Current portion of operating lease liabilities	26,447	26,286
Total current liabilities	479,976	473,721
Long-term obligations, less current portion	351,442	361,862
Operating lease liabilities, less current portion	59,007	62,751
Deferred income tax liabilities	47,212	40,635
Other long-term obligations	845	1,418
Total liabilities	938,482	940,387
Commitments and Contingencies—Note 7
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,248,917 and 38,131,478 shares issued; 32,739,526 and 32,667,631 shares outstanding	38	38
Additional paid-in capital	803,361	787,177
Treasury stock, at cost, 5,509,391 and 5,463,847 shares of common stock	(472,821)	(468,626)
Retained earnings	794,626	747,925
Total Amedisys, Inc. stockholders’ equity	1,125,204	1,066,514
Noncontrolling interests	53,682	53,269
Total equity	1,178,886	1,119,783
Total liabilities and equity	$ 2,117,368	$ 2,060,170